Once daily, high dose versus divided, low dose gentamicin for open fractures

Clinical Orthopaedics and Related Research

Volumn 366, Issue , 1999, Pages 197-204

  Sorger, Joel I ^a,d   Kirk, Patrick G ^a   Ruhnke, Christopher J ^a   Bjornson, Stephen H ^a   Levy, Martin S ^b   Cockrin, James ^b   Tang, Peter ^c  

^a Department of Otolaryngology Head and Neck Surgery   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEPHALOSPORIN; GENTAMICIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEBRIDEMENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRACTURE FIXATION; FRACTURE HEALING; HUMAN; INFECTION RATE; MALE; NEPHROTOXICITY; OPEN FRACTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WOUND IRRIGATION;

EID: 0032871318     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199909000-00026     Document Type: Article

References (28)

1. Blaser J: Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of the ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother 31:1054-1060, 1987.
2. Chan G: Alternative dosing strategy for aminoglycosides: Impact on efficacy nephrotoxicity, and ototoxicity. DICP 23:788-793, 1989.
3. Chapman MW, Mahoney M: The role of early internal fixation in the management of open fractures. Clin Orthop 138:120-131, 1979.
4. Clancy GS, Hansen ST: Open fractures of the tibia: A review of 102 cases. J Bone Joint Surg 60A:118-122, 1978.
5. Cockroft DW Gault MH: Prediction of creatinine clearance form serum creatinine. Nephron 16:31-41, 1976.
6. Dellinger EP, Caplan ES, Weaver LD, et al: Duration of preventive antibiotic administration for extremity fractures. Arch Surg 123:1320-1327, 1988.
7. Dellinger EP, Miller SD, Wertz M J, et al: Risk of infection after open fracture of the arm or leg. Arch Surg 123:1320-1327, 1988.
8. Devries PJ: Prospective randomized study of once-daily versus thrice-daily gentimicin regimens in patients with intra abdominal infection. Eur Clin Microbiol Infect Dis 9:161-168, 1990.
9. Fitzgerald RH: Current concepts of antimicrobial therapy. Instr Course Lect 39:465-470, 1990.
10. Gilbert DN: Once daily aminoglycoside therapy. Antimicrob Agents Chemother 35:399-405, 1991.
11. Gustilo RB: Current concepts in the management of open fractures. Instr Course Lect 36:359-366, 1987.
12. Gustilo RB, Anderson ST: Prevention of infection in the treatment of 1,025 open fractures of long bones: A retrospective and prospective analysis. J Bone Joint Surg 58A:453-458, 1976.
13. Gustilo RB, Merkow RL, Templeman D: Current concept review: The management of open fractures. J Bone Joint Surg 72A:299-304, 1990.
14. Jackson GG, Ancieri G: Ototoxicity of gentamicin in man: A survey and controlled analysis of clinical experience of the U.S. J Infect Dis 124(Suppl):S130-137, 1971.
15. Labovitz E: Single dose daily gentamicin therapy in urinary tract infections. Antimicrob Agents Chemother 6:465-470, 1974.
16. Lietman PS, Smith CR: Aminoglycoside nephrotoxicity in humans. Rev Infect Dis 5(Suppl):S284-293, 1984.
17. Moore RD: Clinical response to aminoglycoside therapy: Importance of ratio of peak concentration to minimum inhibitory concentration. J Infect Dis 155:93-99, 1987.
18. Nev HC, Bendush CL: Ototoxicity of tobramycin: A clinical overview. J Infect Dis 134(Suppl):S206-218, 1976.
19. Patzakis MJ, Harvey P, Ivler D: The role of antibiotics in the management of open fractures. J Bone Joint Surg 56A:532-541, 1974.
20. Patzakis MJ, Wilkins J: Factors influencing infection rate in open fracture wounds. Clin Orthop 243:36-40, 1989.
21. Pierre C: Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers. Clin Pharmacol Ther 44:458-466, 1988.
22. Powell SH: Once daily versus continuous aminoglycoside dosing: Efficacy and toxicity in animal and clinical studies of gentamicin, netilimcin, and tobramycin. J Infect Dis 147:918-932, 1983.
23. Roth JI, Fry DE, Polk HC: Infectious morbidity in extremity fractures. J Trauma 26:757-761, 1986.
24. Sangha K, Miyagawa C, Healy D, Bjornson S, Solomkin J: Pharmacokinetics of once daily dosing of gentamicin in surgical intensive care unit patients with open fractures. Ann Pharmacother 29:117-119, 1995.
25. Van Der Auwera P, Klastersky J: Serum bactericidal activity and post-antibiotic effect in serum of patients with urinary tract infections receiving high dose amikacin. Antimicrob Agents Chemother 31:1061-1068, 1987.
26. Vogelman BS, Craig WA: Post antibiotic effects. J Antimicrob Chemother 15(Suppl A):37-46, 1985.
27. Worlock P, Slack R, Harvey L, Mawhinney R: The prevention of infection in open fractures: An experimental study of the effect of antibiotic therapy. J Bone Joint Surg 70A:1341-1347, 1988.
28. Yourassousky E, Van Der Linden MP, Crokaert F: One shot of high dose amikacin: A working hypothesis. Chemotherapy 36:1-7, 1990.